Market Focus Daily: Friday, June 27, 2025
Japan's Nikkei ends at 6-month high, tracking Wall Street rally; Singapore's job vacancies, unemployment up in Q1, with US tariff impact yet to be seen; Info-Tech Systems launches IPO at S$0.87 apiece, marks SGX's first mainboard listing in two years; Japan's NTT files billion-dollar Reit listing with MAS; IPO set to be SGX's biggest in four years.
Synopsis: Market Focus Daily is a closing bell roundup by The Business Times that looks at the day's market movements and news from Singapore and the region.
Written and hosted by: Emily Liu (emilyliu@sph.com.sg)
Produced and edited by: Chai Pei Chieh & Claressa Monteiro
Produced by: BT Podcasts, The Business Times, SPH Media
---
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Follow BT Market Focus and rate us on:
Channel: bt.sg/btmktfocus
Amazon: bt.sg/mfam
Apple Podcasts: bt.sg/mfap
Spotify: bt.sg/mfsp
YouTube Music: bt.sg/mfyt
Website: bt.sg/mktfocus
Feedback to: btpodcasts@sph.com.sg
Do note: This podcast is meant to provide general information only. SPH Media accepts no liability for loss arising from any reliance on the podcast or use of third party's products and services. Please consult professional advisors for independent advice.
Discover more BT podcast series:
BT Money Hacks at: bt.sg/btmoneyhacks
BT Correspondents: bt.sg/btcobt
BT Podcasts: bt.sg/pcOM
BT Branded Podcasts: bt.sg/btbrpod
BT Lens On: bt.sg/btlenson
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
17 hours ago
- Business Times
Hong Kong-listed China Medical System seeks secondary listing on SGX
[SINGAPORE] Hong Kong-listed China Medical System (CMS) is seeking a secondary listing on the mainboard of the Singapore Exchange (SGX) in July this year. CMS is a specialty pharma with a focus on sales and marketing in China, with capabilities across the full lifecycle of drug development, from identifying clinical needs to research and development (R&D) regulatory approval, and commercialisation. It has been listed on the Stock Exchange of Hong Kong since 2010. The pharmaceutical company expects the secondary listing will help it deepen its presence in South-east Asia and 'tap into a new and sophisticated investor base in Singapore'. CMS said it is looking to replicate its success in South-east Asia – building on the proven track record attained in China's pharmaceutical industry. 'This region, with a population of nearly 700 million, is experiencing surging pharmaceutical demand due to rapid economic growth, the rise of the middle class, ageing population, and the increasing burden of non-infectious diseases,' it said. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Its financial performance in 2023 and 2024 were hit by China's volume-based procurement (VBP) policy – three of its products were included in the VBP list. This policy aims to lower the prices of drugs with generic competition, by guaranteeing certain procurement volumes from public hospitals at significantly reduced prices through a bidding process. But CMS had a top-line rebound in H2 2024, driven by progress in commercialising innovative drugs and the continued growth of non-VBP exclusive products. The company moved towards innovative drugs, given that they typically enjoy a pricing advantage due to their exclusiveness, novelty and quality, and are supported by favourable government policies. It expects growth momentum will accelerate on the back of the replenishment of its pipeline of innovative drugs to about 40 products as at Dec 31, 2024. It noted four key platforms to scale its pharmaceutical ecosystem across Asia-Pacific. CMS R&D is involved in drug discovery and development targeting global markets, while PharmaGend is a development and manufacturing platform for regional manufacturing and supply. It also has Rxilient Health, a Singapore-headquartered entity focused on registration and commercialisation in South-east Asia and a Singapore venture arm, which makes strategic investments to support regional pharma innovation. In a statement on Jun 24, CMS said the proposed listing will not involve issuance of new shares, and the shares will continue to be primarily listed and traded on the Hong Kong Stock Exchange thereafter. Singapore is its regional headquarters for its South-east Asia and Middle East business, the company said. The announcement follows the news of several new listings on SGX – software services provider Info-Tech Systems, a data centre real estate investment trust (Reit) by Japanese telco Nippon Telegraph and Telephone (NTT), and a spin-off of mainboard-listed construction company Lum Chang Holdings' interior fit-out business. Info-Tech Systems, whose shares are expected to begin trading on Jul 4, is the first SGX mainboard listing in two years. NTT DC Reit, which will have a portfolio of six of NTT's data centre assets, will likely be the largest Singapore Reit listing in a decade. Meanwhile, interior fit-out business Lum Chang Creations is looking to list on the Catalist board.
Business Times
a day ago
- Business Times
Mid-year insights: Opportunities amid globalisation's discontents
IN THESE days of waning US-centric investment, some investors are betting that US President Donald Trump's tariff rhetoric may not translate into action, while others pursue strategies tilted toward industrials-heavy nations that may be benefiting from increased defence spending. Either way, the tide turned decidedly global during the first half of 2025. Diversification vs tariff sensitivity Building upon lessons from the Russia-Ukraine war, the United Kingdom recently unveiled plans to significantly raise defence spending and accelerate the development of next-generation security capabilities. The notable rise tracks the trend we've seen in military expenditure across the globe, which reached US$2.7 trillion last year – an increase of 9.4 per cent in real terms from 2023. We believe this localisation of defence production should continue to spur job growth and revitalise smaller industrial centres. South Korea's market has also been lifted given its recent aerospace and defence company gains resulting from global expansion moves and expectations for increased orders on higher European defence spending. A leading South Korean aerospace company formalised its plan to establish a production base in Germany in addition to pursuing other projects in Poland, Romania and Canada, as it moves to strengthen its leadership in the sector. To date this year, South Korea's market saw exchange-traded fund (ETF) net inflows rise more than 121 per cent – higher than any other major Asian economy for the period. It has also widely outperformed the US market year-to-date, returning 21.3 per cent as measured by the Kospi Index (versus 1.1 per cent for the S&P 500 Index). We are optimistic that the recent landslide victory by South Korea's new president Lee Jae-myung can usher in a long-awaited political normalisation for Seoul, following months of political crisis stemming from the impeachment of the country's former leader in December. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Eurozone/Germany For the second half of the year, we foresee ongoing opportunities in Germany and the eurozone, which offer differentiated sector allocation compared to the tech-heavy S&P 500 Index. By contrast, Germany's information technology (IT) sector is its third largest. Similarly, the Stoxx Europe 600 Index holds top weightings in financials (around 23 per cent) and industrials (about 19 per cent) firms, with IT making up just 7 per cent of the index. Europe's stock market got an early boost in March when German officials proposed spending hundreds of billions of euros on infrastructure and defence, a notable departure from Berlin's reputation for fiscal austerity. In a significant turnaround for the long-sluggish market, the Stoxx 600 Index outpaced the S&P 500 by about 20 percentage points in US dollar (USD) terms at the end of May. Moreover, the US administration is considering taxing foreign owners of US assets from countries with 'unfair' tax practices, a move that could potentially discourage capital inflows and weaken the USD. This is leading investors to reassess their dollar exposure, particularly after April's simultaneous selloff in US stocks, bonds and USD, which revealed reduced diversification benefits. We believe a stronger euro, resilient corporate earnings and attractive valuations are making the region increasingly appealing, drawing investor attention back to the eurozone. Year-to-date, ETFs focused on the Europe region drew net flows of US$33 billion, bringing total net inflows to US$238.97 billion. Net ETF inflows have risen 19 per cent year-to-date. Germany's proposed infrastructure spending alone, by some estimates, may raise economic output by more than two percentage points per year over the next decade. Such comprehensive reforms stand to benefit not only its defence sector but the overall economy by stimulating job growth and key development areas such as manufacturing, green technology, and digital infrastructure. Titans of Latin America: Mexico and Brazil Notwithstanding the current uncertainties over tariffs facing steel industry exports to the United States, we believe Mexico should continue to benefit by capturing a disproportionate share of nearshoring opportunities. Whether Trump can justify his tariff policy in the courts remains to be seen, and steel duties facing Brazil and Mexico pose key risks, in our opinion. Mexico is also coping with a marked decline in remittances – a significant component to its economy – which recently registered their largest annual drop in more than a decade as US lawmakers mull taxing the transfers and continue with crackdowns on immigration. Last year, Mexico received nearly US$65 billion in remittances – roughly 3.5 per cent of its gross domestic product. An extended decline could affect consumption in Latin America's second-largest economy. Mexico's stock market, however, is heavily weighted toward sectors like consumer staples and communication services, known for their stable cash flows and reliable dividends, offering some resilience in uncertain times. In our analysis, valuations also appear attractive compared to historical averages: Over the past five years, the average 12-month adjusted price-to-earnings ratio for Mexican stocks was some 19 times. Currently, the S&P/BMV Total Mexico Index is trading at 12.6 times, based on forward earnings estimates. Brazil As companies continue to pivot to a 'China plus' strategy – maintaining operations in China while expanding production elsewhere – we believe Brazil may also be poised to benefit. China, Brazil's largest trading partner, is already shifting further demand for agricultural goods to Brazil, which was spared more of a direct hit in the tariff war as the country faces the lowest level of reciprocal US tariffs. President Luiz Inácio Lula da Silva's recent visit to Beijing resulted in planned investments and agreements of about US$4.8 billion, underscoring Brazil's growing economic ties with China. Despite the country's current fiscal challenges, we believe Brazil's strategic positioning as a key commodity exporter, particularly in soybeans and meat, should bode well for its economic growth. During the second half of this year, politics should weigh more heavily on Brazil's market with its 2026 presidential election coming into clearer focus. Given Lula's low approval ratings, concerns over his health (emergency brain surgeries and chemotherapy treatments) and age (81), there is speculation that fresh candidates may emerge and increase the potential for markets to react positively to any signs of change. Over the near term, we'll be keeping close tabs on the divergence of each country and region's unique characteristics as they highlight the varying opportunities and risks, especially amid Trump's particular approach to reciprocal policymaking, and underscore the need for more nuanced investment strategies. The writer is head of global index portfolio management at Franklin Templeton
Business Times
a day ago
- Business Times
Europe: Stocks rise as US-China trade tensions ease; auto stocks jump
[BENGALURU] European stocks closed at an over one-week high on Friday (Jun 27), fuelled by a rally in automakers, as investors took more risks on hopes for a truce in the US-China trade spat. The pan-European Stoxx 600 index closed 1.1 per cent higher, snapping a two-week losing streak and posting its first weekly gain in three. German stocks notched their strongest weekly rally in two months, while France and Spain's main indices clocked their best weeks in over a month. The Stoxx 600's energy sector, however, suffered its first weekly drop in weeks. The sector lost steam as oil prices plunged, after fears of a closure of the Strait of Hormuz – crucial to global supply – subsided following a 12-day conflict between Israel and Iran. 'We are surprised to see continued market strength in light of the current geopolitical events, but it's clear that the market thinks the conflict will remain contained, although that could change at anytime,' said Robert Ruggirello, chief investment officer, Brave Eagle Wealth Management. With geopolitical worries in the Middle East receding, investors have shifted their gaze to global trade developments. They are hoping for breakthroughs on new trade deals before the looming deadline for higher US tariffs in early July. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up A White House official revealed on Thursday that Washington and Beijing had struck a deal to fast-track rare earth shipments to the US. European auto stocks and the luxury sector, particularly sensitive to China-related headlines, jumped 4.1 per cent and 2.5 per cent, respectively, steering sectoral advances. Porsche jumped 7.6 per cent after Handelsblatt reported that the carmaker was looking to sell its consulting and IT services business MHP, which could be valued at over one billion euros (S$1.5 billion). Adding to the tailwinds, US Treasury Secretary Scott Bessent on Thursday asked Republicans in Congress to remove a 'retaliatory tax' proposal that would let Trump impose up to 20 per cent taxes on foreign investors from countries that levy 'unfair' taxes on US firms. Meanwhile, EU leaders discussed new proposals from the US on a trade deal at a summit in Brussels on Thursday. European Commission President Ursula von der Leyen did not rule out the likelihood of tariff talks failing, saying 'all options remain on the table'. 'There's lots of negotiation going on and it takes time... but any sign that tensions are not going to re-escalate, would be taken positively,' said Richard Flax, chief investment officer at Moneyfarm. Global market sentiment also received an extra boost from Wall Street, as both the S&P 500 and Nasdaq opened at record highs. On the data front, French consumer prices unexpectedly climbed in June, snapping a run of falling inflation, while Spain also saw its inflation rate tick higher during the month. UK's JD Sports advanced 7.6 per cent, while German sportswear makers Puma and Adidas gained 3 per cent and 3.8 per cent, respectively, after US peer Nike's first-quarter revenue outlook exceeded market expectations. Amplifon dropped 7.3 per cent after brokerage Exane BNP Paribas flagged weak consumer sentiment in the hearing aid company's main markets. REUTERS